2014-1294 - Purdue Pharma LP v. Epic Pharma LLCReport Error
Detail
Case Number
2014-1294Current Status
closedCause of Action
N/ARelated Case(s)
1:13-cv-00683
2014-1296
2014-1306
2014-1307
2014-1311
2014-1312
2014-1313
2014-1314
2015-1654
2015-1990
2016-1752
Court
Court of Appeals for the Federal CircuitPlaintiff(s)
Purdue Pharma LP
Defendant(s)
Epic Pharma LLC
Judge
Sidney H. SteinFiling Date
2014-02-19Termination Date
2016-02-01Dockets
| Text |
|---|
| Appeal docketed. Received: 02/18/2014. [136528] Entry of Appearance due 03/05/2014. Certificate of Interest is due on 03/05/2014. Docketing Statement due 03/05/2014. Appellant/Petitioner's brief is due 04/21/2014 (02/19/2014) |
| Final Civil Docket 02-01-2016 |
| Appeal docketed. Received: 02/18/2014. [136528] Entry of Appearance due 03/05/2014. Certificate of Interest is due on 03/05/2014. Docketing Statement due 03/05/2014. Appellant/Petitioners brief is due 04/21/2014. [LP] [Entered: 02/19/2014 10:57 AM] |
| Entry of appearance for Robert J. Goldman as principal counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 02/27/2014 by email. [138699] [Robert Goldman] [Entered: 02/27/2014 02:57 PM] |
| Certificate of Interest for the Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 02/27/2014 by email. [138700] [Robert Goldman] [Entered: 02/27/2014 03:01 PM] |
| MOTION of Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc. to stay appeal. Response/Opposition is due 03/13/2014 [Consent: unopposed]. Service: 02/27/2014 by email. [138751] [Robert Goldman] [Entered: 02/27/2014 06:01 PM] |
| Objection to the official caption pursuant to Rule 12 Practice Note by Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 03/05/2014 by email. [139847] [Robert Goldman] [Entered: 03/05/2014 04:37 PM] |
| Notice of intent to file corresponding briefs on CD-ROM for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 03/05/2014 by email. [139849] [Robert Goldman] [Entered: 03/05/2014 04:39 PM] |
| Docketing Statement for the Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 03/05/2014 by email. [139852] [Robert Goldman] [Entered: 03/05/2014 04:43 PM] |
| Entry of appearance for Thomas J. Vetter as principal counsel for Appellee Epic Pharma, LLC. Service: 03/05/2014 by email. [139861] [Thomas Vetter] [Entered: 03/05/2014 05:07 PM] |
| Certificate of Interest for the Appellee Epic Pharma, LLC. Service: 03/05/2014 by email. [139862] [Thomas Vetter] [Entered: 03/05/2014 05:08 PM] |
| Docketing Statement for the Appellee Epic Pharma, LLC. Service: 03/05/2014 by email. [139863] [Thomas Vetter] [Entered: 03/05/2014 05:08 PM] |
| MOTION of Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc. to consolidate appeals (2014-1294; 2014-1296; 2014-1306 -1307; 2014-1311 -1312 -1313- 1314 ). Response/Opposition is due 03/20/2014 [Consent: unopposed]. Service: 03/07/2014 by email. [140411] [Robert Goldman] [Entered: 03/07/2014 03:42 PM] |
| ORDER granting motion to consolidate appeals [11] filed by Appellants Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.p. and Rhodes Technologies. 2014-1294, 2014-1296, 2014-1306, 2014-1307, 2014-1311, 2014-1312, 2014-1313, and 2014-1314 are consolidated. The revised official caption is reflected in the order. The consolidated appeals [4] are stayed pending resolution of Teva Pharmaceuticals USA, Inc.s motion to amend the judgment in the district court. Within 14 days of resolution of that motion, Purdue shall file a status report in the consolidated appeals proposing a briefing schedule. Service: 03/12/2014 by clerk. [141325] [LMS] [Entered: 03/12/2014 12:14 PM] |
| Objection to the official caption pursuant to Rule 12 Practice Note by Appellants Grunenthal Gmbh, Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 03/25/2014 by email. [143850] [Robert Goldman] [Entered: 03/25/2014 04:14 PM] |
| Letter from Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc. to notify the Court of an omission in the CM/ECF General Docket. Service: 03/25/2014 by email. [143851] [Robert Goldman] [Entered: 03/25/2014 04:18 PM] |
| Entry of appearance for Christopher J. Harnett as of counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 03/25/2014 by email. [143855] [Christopher Harnett] [Entered: 03/25/2014 04:25 PM] |
| Entry of appearance for Pablo D. Hendler as of counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 03/25/2014 by email. [143864] [Pablo Hendler] [Entered: 03/25/2014 04:43 PM] |
| Entry of appearance for Sona De as of counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 03/25/2014 by email. [143866] [Sona De] [Entered: 03/25/2014 04:53 PM] |
| Entry of appearance for John J. Normile as of counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 04/07/2014 by email. [146254] [Jennifer Swize] [Entered: 04/07/2014 11:20 AM] |
| Entry of appearance for Gregory A. Castanias as of counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 04/07/2014 by email. [146256] [Jennifer Swize] [Entered: 04/07/2014 11:21 AM] |
| Entry of appearance for Jennifer L. Swize as of counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 04/07/2014 by email. [146259] [Jennifer Swize] [Entered: 04/07/2014 11:22 AM] |
| Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 04/07/2014 by email. [146402] [Robert Goldman] [Entered: 04/07/2014 03:54 PM] |
| Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Grunenthal Gmbh. Service: 04/07/2014 by email. [146403] [Basil Lewris] [Entered: 04/07/2014 03:54 PM] |
| Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 04/07/2014 by email. [146509] [Eric Hunt] [Entered: 04/07/2014 08:44 PM] |
| Amended Entry of appearance for Thomas J. Vetter as principal counsel for Appellee Epic Pharma, LLC. Service: 04/08/2014 by email. [146847] [Thomas Vetter] [Entered: 04/08/2014 06:04 PM] |
| Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Epic Pharma, LLC. Service: 04/08/2014 by email. [146849] [Thomas Vetter] [Entered: 04/08/2014 06:06 PM] |
| ORDER modifying the official caption. The revised official caption is reflected in the order. Service: 04/09/2014 by clerk. [146966] [LMS] [Entered: 04/09/2014 12:07 PM] |
| Note to file: The following cases are associated:14-1294 Lead with 14-1312 Consolidated Appeal. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [147018] [JXB] [Entered: 04/09/2014 02:39 PM] |
| Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Amneal Pharmaceuticals, LLC. Service: 04/09/2014 by email. [147060] [Angela Verrecchio] [Entered: 04/09/2014 03:42 PM] |
| Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Teva Pharmaceuticals USA, Inc.. Service: 04/11/2014 by email. [147606] [Mark Schuman] [Entered: 04/11/2014 04:31 PM] |
| Status report for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 05/01/2014 by email. [151878] [Jennifer Swize] [Entered: 05/01/2014 11:18 PM] |
| ORDER filed. The consolidated appeals shall remain stayed pending the docketing of the parties notices of appeal from the district courts amended judgment. The court will set a briefing schedule once the stay is lifted. The parties are directed to file a status report within 30 days of the date of this order as to how these appeals should proceed. Service: 05/14/2014 by clerk. [154447] [LMS] [Entered: 05/14/2014 12:51 PM] |
| Status report for Appellants Grunenthal Gmbh, Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies, The P.F. Laboratories, Inc. and Appellees Amneal Pharmaceuticals, LLC, Epic Pharma, LLC, Mylan Inc., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals USA, Inc.. Service: 06/13/2014 by email. [161483] [Jennifer Swize] [Entered: 06/13/2014 06:21 PM] |
| ORDER filed. The consolidated appeals shall remain stayed pending the docketing of the parties notices of appeal from the district courts amended judgment. The court will set a briefing schedule once the stay is lifted. The parties are directed to file a status report within 14 days of the date of docketing of appellants notices of appeal from the district courts amended judgment as to how these appeals should proceed. Service: 06/20/2014 by clerk. [162840] [LMS] [Entered: 06/20/2014 12:32 PM] |
| Entry of appearance for Charles E. Lipsey as of counsel for Appellant Grunenthal Gmbh. Service: 07/01/2014 by email. [164764] [Charles Lipsey] [Entered: 07/01/2014 05:52 PM] |
| Amended Certificate of Interest for the Appellant Grunenthal Gmbh. Service: 07/01/2014 by email. [164765] [Basil Lewris] [Entered: 07/01/2014 05:56 PM] |
| Received from the U.S. District Court, Amended Notices of Appeal for consolidated appeals by Grunenthal (14-1306, -1311, -1313); Purdue Pharma et al. (14-1307, -1312, -1314). [170571] [AT] [Entered: 07/25/2014 03:10 PM] |
| Status report for Appellants Grunenthal Gmbh, Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies, The P.F. Laboratories, Inc. and Appellees Amneal Pharmaceuticals, LLC, Epic Pharma, LLC, Mylan Inc., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals USA, Inc.. Service: 07/25/2014 by email, US mail. [170744] [Jennifer Swize] [Entered: 07/25/2014 08:14 PM] |
| ORDER filed. The stay in the above-captioned consolidated appeals is lifted. Appellants opening briefs shall be due no later than 60 days after the date of filing of this order. Service: 08/07/2014 by clerk. [173591] [LMS] [Entered: 08/07/2014 02:19 PM] |
| Entry of Appearance for Appellee Teva Pharmaceuticals USA, Inc.. Service: 08/21/2014 by email. [176967] [Mark Schuman] [Entered: 08/21/2014 05:33 PM] |
| Entry of appearance for Jeffer Ali as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 08/21/2004 by email. [176968] [M. Ali] [Entered: 08/21/2014 05:38 PM] |
| Entry of appearance for Jennell Bilek as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 08/21/2014 by email. [176970] [M. Ali] [Entered: 08/21/2014 05:41 PM] |
| Entry of appearance for Mark Schuman as principal counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 08/21/2014 by email. [176972] [M. Ali] [Entered: 08/21/2014 05:43 PM] |
| Entry of appearance for Sarah Stensland as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 08/21/2014 by email. [176977] [M. Ali] [Entered: 08/21/2014 05:46 PM] |
| Entry of appearance for Todd Werner as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 08/21/2014 by email. [176979] [M. Ali] [Entered: 08/21/2014 05:48 PM] |
| Entry of appearance for Meredith Martin Addy as of counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 08/21/2014 by email, US mail. [176986] [Meredith Addy] [Entered: 08/21/2014 05:55 PM] |
| MOTION of Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc. to withdraw counsel Meredith Martin Addy. Response/Opposition is due 09/05/2014 [Consent: not addressed]. Service: 08/22/2014 by email, US mail. [177278] [Meredith Addy] [Entered: 08/22/2014 05:12 PM] |
| ORDER granting motion to withdraw Meredith Martin Addy [46] filed by Appellants Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.p. and Rhodes Technologies. Service: 09/04/2014 by clerk. [179975] [LMS] [Entered: 09/04/2014 12:36 PM] |
| TENDERED from Appellant Grunenthal Gmbh. Title: OPENING BRIEF. Service: 10/06/2014 by email. [188080] [Charles Lipsey] [Entered: 10/06/2014 05:12 PM] |
| TENDERED from Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Title: OPENING BRIEF. Service: 10/06/2014 by email, US mail. [188133] [Jennifer Swize] [Entered: 10/06/2014 09:52 PM] |
| Official caption revised pursuant to the courts order filed 4/9/14. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [189144] [AT] [Entered: 10/10/2014 12:27 PM] |
| BRIEF FILED for Appellant Grunenthal Gmbh [48]. Title: OPENING BRIEF. Number of Pages: 52. Service: 10/06/2014 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 10/15/2014. The brief for appellees Amneal Pharmaceuticals, LLC, Epic Pharma, LLC, Mylan Inc., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals USA, Inc. is due 11/20/2014. [189147] [AT] [Entered: 10/10/2014 12:30 PM] |
| BRIEF FILED for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc. [49]. Title: OPENING BRIEF. Number of Pages: 66. Service: 10/06/2014 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 10/15/2014. [189149] [AT] [Entered: 10/10/2014 12:32 PM] |
| 6 paper copies of the 1st brief [51] received from Appellant Grunenthal Gmbh. [189472] [AT] [Entered: 10/14/2014 12:12 PM] |
| Entry of appearance for Benjamin C. Block as principal counsel for Center for Lawful Access and Abuse Deterrence. Service: 10/14/2014 by email. [189475] [Benjamin Block] [Entered: 10/14/2014 12:15 PM] |
| Entry of appearance for Donald E. Knebel as principal counsel for Amici Curiae Donald E. Knebel and Mark D. Janis. Service: 10/14/2014 by email. [189578] [Donald Knebel] [Entered: 10/14/2014 02:51 PM] |
| Entry of appearance for Mark D. Janis as of counsel for Amici Curiae Donald E. Knebel and Mark D. Janis. Service: 10/14/2014 by email. [189582] [Mark Janis] [Entered: 10/14/2014 02:54 PM] |
| MOTION of Amici Curiae Donald E. Knebel and Mark D. Janis for leave to file an amicus curiae brief. Response/Opposition is due 10/27/2014 [Consent: partial consent]. Service: 10/14/2014 by email. [189591] [Donald Knebel] [Entered: 10/14/2014 02:59 PM] |
| MOTION of Center for Lawful Access and Abuse Deterrence for leave to file an amicus curiae brief. Response/Opposition is due 10/27/2014 [Consent: opposed]. Service: 10/14/2014 by email. [189592] [Benjamin Block] [Entered: 10/14/2014 03:00 PM] |
| TENDERED from Amici Curiae Donald E. Knebel and Mark D. Janis Title: AMICUS CURIAE BRIEF. Service: 10/14/2014 by email, US mail. [189596] [Donald Knebel] [Entered: 10/14/2014 03:02 PM] |
| TENDERED from Center for Lawful Access and Abuse Deterrence Title: AMICUS CURIAE BRIEF. Service: 10/14/2014 by email. [189780] [Benjamin Block] [Entered: 10/14/2014 10:49 PM] |
| MOTION of Center for Lawful Access and Abuse Deterrence for leave to file an amicus curiae brief. Response/Opposition is due 10/27/2014, to correct or supplement [Corrected Motion for Leave To File Brief Amicus Curiae removing Brief as attachment to the motion and instead lodging brief with the Court via separate ECF transaction]. Response/Opposition is due 10/27/2014 [Consent: partial consent]. Service: 10/14/2014 by email. [189781] [Benjamin Block] [Entered: 10/14/2014 11:04 PM] |
| ORDER filed. Any opposition to the motion for leave to file an amicus curiae brief [61], [58], [57] is due within seven days of the date of filing of this order. Any reply by the movant is due within 3 days of the date of filing of the opposition. Service: 10/15/2014 by clerk. [190003] [LMS] [Entered: 10/15/2014 01:47 PM] |
| 6 paper copies of the 1st brief [52] received from Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc. [190087] [AT] [Entered: 10/15/2014 03:57 PM] |
| RESPONSE of Appellee Teva Pharmaceuticals USA, Inc. to the motion for leave to file an amicus curiae brief [61] , motion to correct/supplement other [61]. Service: 10/22/2014 by email. [191848] [Mark Schuman] [Entered: 10/22/2014 05:44 PM] |
| NOTICE OF DEFICIENCY: The response Docket No. [64] filed by Appellee Teva Pharmaceuticals USA, Inc. in 14-1294 is submitted without the required prerequisite entry of appearance for counsel ALEXANDRA J. OLSON. You are being afforded the opportunity to correct the deficiency. ALEXANDRA J. OLSON should enter her appearance in this matter immediately. [191872] [AT] [Entered: 10/23/2014 07:57 AM] |
| Entry of appearance for Alexandra J. Olson as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 10/23/2014 by email. [192048] [Alexandra Olson] [Entered: 10/23/2014 12:23 PM] |
| REPLY of Center for Lawful Access and Abuse Deterrence to response filed by Appellee in 14-1294 , Doc. No [64]. Service: 10/24/2014 by email. [192357] [Benjamin Block] [Entered: 10/24/2014 12:04 PM] |
| NOTICE OF DEFICIENCY: The attorney entry of appearance [A. OLSON] Docket No. [66] filed by Appellee Teva Pharmaceuticals USA, Inc. in 14-1294 is not text searchable and contains no proof of service and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [192366] [AT] [Entered: 10/24/2014 12:23 PM] |
| Entry of appearance for Alexandra J. Olson as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 10/24/2014 by email. [192483] [Alexandra Olson] [Entered: 10/24/2014 03:08 PM] |
| ORDER granting motion for leave to file an amicus curiae brief [57] filed by Donald E. Knebel and Mark D. Janis to the extent that the brief is accepted. Service: 10/31/2014 by clerk. [194203] [LMS] [Entered: 10/31/2014 09:26 AM] |
| AMICUS BRIEF FILED for Mark David Janis and Donald E. Knebel [59]. Number of Pages: 10. Service: 10/14/2014 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 11/05/2014. [194301] [AT] [Entered: 10/31/2014 11:43 AM] |
| Corrected Certificate of Interest for the Appellee Amneal Pharmaceuticals, LLC. Service: 11/03/2014 by email, US mail. [194698] [Jason Weil] [Entered: 11/03/2014 03:12 PM] |
| MOTION of Appellees Amneal Pharmaceuticals, LLC and Teva Pharmaceuticals USA, Inc. to extend the time to 01/20/2015 to file the appellee/respondent/cross-appellants principal brief. Response/Opposition is due 11/17/2014 [Consent: opposed]. Service: 11/03/2014 by email, US mail. [194715] [Jason Weil] [Entered: 11/03/2014 03:24 PM] |
| MOTION of Appellees Amneal Pharmaceuticals, LLC and Teva Pharmaceuticals USA, Inc. to File Separate Response Briefs. Response/Opposition is due 11/17/2014 [Consent: opposed]. Service: 11/03/2014 by email, US mail. [194721] [Jason Weil] [Entered: 11/03/2014 03:29 PM] |
| MOTION of Appellee Epic Pharma, LLC to extend the time to 01/20/2015 to file the appellee/respondent/cross-appellants principal brief. Response/Opposition is due 11/17/2014 [Consent: opposed]. Service: 11/04/2014 by email. [195135] [Thomas Vetter] [Entered: 11/04/2014 06:22 PM] |
| MOTION of Appellees Mylan Inc. and Mylan Pharmaceuticals Inc. to extend the time to 01/20/2015 to file the appellee/respondent/cross-appellants principal brief. Response/Opposition is due 11/17/2014 [Consent: opposed]. Service: 11/04/2014 by email. [195146] [Eric Hunt] [Entered: 11/04/2014 09:58 PM] |
| 6 paper copies of the amicus Brief [71] received from Amici Curiae Mark David Janis and Mr. Donald E. Knebel. [195170] [AT] [Entered: 11/05/2014 09:02 AM] |
| ORDER granting motions to extend time to file appellees response briefs [73] [75] [76] [74] filed by Appellees. The response briefs are due on or before January 20, 2015. Service: 11/06/2014 by clerk. [195554] [LMS] [Entered: 11/06/2014 10:41 AM] |
| ORDER filed granting motion for leave to file an amicus curiae brief [58] [61] filed by Center for Lawful Access and Abuse Deterrence. The brief (Docket Entry 60) is accepted for filing. Service: 11/10/2014 by clerk. [196225] [LMS] [Entered: 11/10/2014 08:43 AM] |
| AMICUS BRIEF FILED for Center for Lawful Access and Abuse Deterrence [60]. Number of Pages: 14. Service: 10/14/2014 by email. [196568] [AT] [Entered: 11/10/2014 03:45 PM] |
| 6 paper copies of the amicus Brief [80] received from Amicus Curiae Center for Lawful Access and Abuse Deterrence. [196574] [AT] [Entered: 11/10/2014 03:48 PM] |
| RESPONSE of Appellants Grunenthal Gmbh, Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc. to the motion for other relief [74] filed by Appellees Teva Pharmaceuticals USA, Inc. and Amneal Pharmaceuticals, LLC in 14-1294. Service: 11/14/2014 by email, US mail. [197737] [Jennifer Swize] [Entered: 11/14/2014 12:20 PM] |
| REPLY of Appellees Amneal Pharmaceuticals, LLC and Teva Pharmaceuticals USA, Inc. to response filed by Appellants in 14-1294 , Doc. No [82]. Service: 11/19/2014 by email, US mail. [198854] [Barbara Mullin] [Entered: 11/19/2014 04:48 PM] |
| Entry of appearance for Emily C. Johnson as of counsel for Appellees Amneal Pharmaceuticals, LLC and Teva Pharmaceuticals USA, Inc.. Service: 12/19/2014 by email, US mail. [205449] [Emily Johnson] [Entered: 12/19/2014 03:39 PM] |
| Notice from Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies, The P.F. Laboratories, Inc. and Appellee Teva Pharmaceuticals USA, Inc. Nonconfidential Notice of Confidential Document. Service: 12/23/2014 by email, US mail. [206070] [Jennifer Swize] [Entered: 12/23/2014 08:45 PM] |
| Sealed or confidential document received [Confidential Notice of Confidential Document] (corresponding to Doc No. [85]) for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies, The P.F. Laboratories, Inc. and Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/23/2014 by email. [206071] [Jennifer Swize] [Entered: 12/23/2014 08:53 PM] |
| ORDER filed. Teva Pharmaceuticals USA, Inc. and Amneal Pharmaceuticals, LLCs motion for leave to file separate response briefs, or in the alternative, to file a single response brief with a 21,000 word limit is denied. Movants response brief, not to exceed 14,000 words, is due on or before January 20, 2015. Service: 12/24/2014 by clerk. [206108] [LMS] [Entered: 12/24/2014 11:08 AM] |
| MOTION of Appellee Teva Pharmaceuticals USA, Inc. to withdraw counsel Barbara L. Mullin Steven D. Maslowski Matthew A. Pearson Angela Verrecchio Jason Weil Emily C. Johnson. Response/Opposition is due 01/12/2015 [Consent: unopposed]. Service: 12/30/2014 by email, US mail. [206705] [Barbara Mullin] [Entered: 12/30/2014 04:08 PM] |
| Amended Certificate of Interest for the Appellee Amneal Pharmaceuticals, LLC. Service: 01/05/2015 by email, US mail. [207207] [Barbara Mullin] [Entered: 01/05/2015 03:16 PM] |
| Entry of appearance for Christopher A. Pinahs as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 01/05/2015 by email. [207228] [Christopher Pinahs] [Entered: 01/05/2015 03:54 PM] |
| MOTION of Appellee Amneal Pharmaceuticals, LLC to reconsider court order [87],court order for other relief [87]. Response/Opposition is due 01/20/2015 [Consent: opposed]. Service: 01/05/2015 by email, US mail. [207297] [Barbara Mullin] [Entered: 01/05/2015 06:28 PM] |
| ORDER filed. A copy of Purdue and Tevas letter and attachments and this order shall be transmitted to the merits panel assigned to decide this case.; - FOR CALENDAR. Service: 01/07/2015 by clerk. [207853] [LMS] [Entered: 01/07/2015 12:58 PM] |
| ORDER granting motion to withdraw Barbara L. Mullin, Steven D. Maslowski, Angela Verrecchio, Matthew A. Pearson, Jason Weil, and Emily C. Johnson as counsel for Teva Pharmaceuticals USA, Inc. [88] filed by Appellee Teva Pharmaceuticals USA, Inc.; Any opposition to the motion for reconsideration [91] shall be filed no later than seven days after the issuance of this order. Any reply is due no later than three days from the date of service of the response. Service: 01/07/2015 by clerk. [207865] [LMS] [Entered: 01/07/2015 01:17 PM] |
| NOTICE OF DEFICIENCY: The certificate of interest Document No. [89] filed by Appellee Amneal Pharmaceuticals, LLC in 14-1294 is submitted using an incorrect docket number and caption therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [207915] [KJ] [Entered: 01/07/2015 02:31 PM] |
| Amended Certificate of Interest for the Appellee Amneal Pharmaceuticals, LLC. Service: 01/07/2015 by email, US mail. [208016] [Barbara Mullin] [Entered: 01/07/2015 04:22 PM] |
| MOTION of Appellees Mylan Inc. and Mylan Pharmaceuticals Inc. to Compel Production of Settlement Documents. Response/Opposition is due 01/26/2015, to extend the time to 30 Days Following Resolution of Mylans Motion to Compel Production of Settlement Documents to file the appellee/respondent/cross-appellants principal brief. Response/Opposition is due 01/26/2015 [Consent: partial consent]. Service: 01/12/2015 by email, US mail. [209048] [Eric Hunt] [Entered: 01/12/2015 04:34 PM] |
| MOTION of Appellee Teva Pharmaceuticals USA, Inc. to Dismiss. Response/Opposition is due 01/26/2015 [Consent: opposed]. Service: 01/12/2015 by email. [209081] [Jennell Bilek] [Entered: 01/12/2015 06:08 PM] |
| Additional volumes of motion for other relief [97] filed by Appellee Teva Pharmaceuticals USA, Inc. in 14-1294. Service: 01/12/2015 by email. [209083] [Jennell Bilek] [Entered: 01/12/2015 06:14 PM] |
| Sealed or confidential document received [Tevas Opposed Motion to Dismiss] for Appellee Teva Pharmaceuticals USA, Inc.. Service: 01/12/2015 by email. [209086] [Jennell Bilek] [Entered: 01/12/2015 06:29 PM] |
| Notice of Rejection to Appellee Teva Pharmaceuticals USA, Inc., the following document(s) is REJECTED for filing: motion for other relief [to dismiss appeals] [97]. Reason(s): the incorrect motion relief was selected. Service: 01/13/2015 by clerk. [209376] [AT] [Entered: 01/13/2015 02:42 PM] |
| MOTION of Appellee Teva Pharmaceuticals USA, Inc. to terminate cross/consolidated appeal. Response/Opposition is due 01/26/2015 [Consent: opposed]. Service: 01/13/2015 by email. [209436] [Jennell Bilek] [Entered: 01/13/2015 03:47 PM] |
| MOTION of Appellee Amneal Pharmaceuticals, LLC to extend the time to 30 days after the court rules on last pending Motion to file the appellee/respondent/cross-appellants principal brief. Response/Opposition is due 01/26/2015 [Consent: opposed]. Service: 01/13/2015 by email, US mail. [209516] [Barbara Mullin] [Entered: 01/13/2015 05:29 PM] |
| Entry of appearance for Natasha L. White as of counsel for Appellees Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 01/13/2015 by email. [209527] [Natasha White] [Entered: 01/13/2015 06:38 PM] |
| MOTION of Appellee Teva Pharmaceuticals USA, Inc. to extend the time to 30 days after the court rules on last of pending Motions filed as D.I. 91 and D.I. 97 to file the appellee/respondent/cross-appellants principal brief. Response/Opposition is due 01/26/2015 [Consent: opposed]. Service: 01/13/2015 by email. [209533] [Jennell Bilek] [Entered: 01/13/2015 07:43 PM] |
| CLERKS OFFICE QUALITY CONTROL MESSAGE: re: Tevas motion to terminate cross/consolidated appeal Docket No. [101], ERROR: Tevas re-filed Motion to Dismiss appears to omit Exhibits A,B,C,D which were part of the originally-filed motion; in addition the re-filed motion is not text-searchable. CORRECTION: Teva may wish to file a corrected motion if the exhibits were omitted in error. If motion is re-filed, please convert it to text-searchable format prior to filing. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [209652] [AT] [Entered: 01/14/2015 11:00 AM] |
| MOTION of Appellee Teva Pharmaceuticals USA, Inc. to terminate cross/consolidated appeal. Response/Opposition is due 01/29/2015 [Consent: opposed]. Service: 01/14/2015 by email. [209862] [Jennell Bilek] [Entered: 01/14/2015 04:00 PM] |
| RESPONSE of Appellants Grunenthal Gmbh, Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc. to the motion to reconsider order [91] filed by Appellee Amneal Pharmaceuticals, LLC in 14-1294. Service: 01/14/2015 by email. [209943] [Jennifer Swize] [Entered: 01/14/2015 09:50 PM] |
| REPLY of Appellee Amneal Pharmaceuticals, LLC to response filed by Appellants in 14-1294 , Doc. No [107]. Service: 01/15/2015 by email, US mail. [210194] [Barbara Mullin] [Entered: 01/15/2015 03:09 PM] |
| ORDER granting motions to extend time to file appellees responsive briefs [104] [102] to the extent that the briefing schedule is stayed. The Court will lift the stay and set a briefing schedule in these consolidated appeals upon disposition of Tevas motion to dismiss. Service: 01/15/2015 by clerk. [210251] [LMS] [Entered: 01/15/2015 04:00 PM] |
| ORDER filed granting motion for reconsideration [91] filed by Appellee Amneal Pharmaceuticals, LLC. Amneal and Teva each may file a responsive brief, each not to exceed 14,000 words. Service: 01/22/2015 by clerk. [211782] [LMS] [Entered: 01/22/2015 02:46 PM] |
| RESPONSE of Appellee Teva Pharmaceuticals USA, Inc. to the motion for other relief [96] filed by Appellees Mylan Pharmaceuticals Inc. and Mylan Inc. in 14-1294 , motion to extend time to file appellee/respondent/cross-appellant principal brief [96] filed by Appellees Mylan Pharmaceuticals Inc. and Mylan Inc. in 14-1294. Service: 01/26/2015 by email, US mail. [212787] [Jennell Bilek] [Entered: 01/26/2015 06:33 PM] |
| RESPONSE of Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc. to the motion to terminate cross/consolidated appeal [106] filed by Appellee Teva Pharmaceuticals USA, Inc. in 14-1294 , motion to terminate cross/consolidated appeal [101] filed by Appellee Teva Pharmaceuticals USA, Inc. in 14-1294 , motion for other relief [97] filed by Appellee Teva Pharmaceuticals USA, Inc. in 14-1294. Service: 01/26/2015 by email, US mail. [212802] [Jennifer Swize] [Entered: 01/26/2015 11:39 PM] |
| RESPONSE of Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc. to the motion to terminate cross/consolidated appeal [106] filed by Appellee Teva Pharmaceuticals USA, Inc. in 14-1294 , motion to terminate cross/consolidated appeal [101] filed by Appellee Teva Pharmaceuticals USA, Inc. in 14-1294 , motion for other relief [97] filed by Appellee Teva Pharmaceuticals USA, Inc. in 14-1294. Service: 01/26/2015 by email, US mail. [212803]--[THIS ENTRY EDITED 01/27/2015 by Sr. Dep. Clk. A Tomlinson TO MODIFY THE DOCUMENT ACCESS TO COURT ONLY] [Jennifer Swize] [Entered: 01/26/2015 11:44 PM] |
| RESPONSE of Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc. to the motion for other relief [96] filed by Appellees Mylan Pharmaceuticals Inc. and Mylan Inc. in 14-1294 , motion to extend time to file appellee/respondent/cross-appellant principal brief [96] filed by Appellees Mylan Pharmaceuticals Inc. and Mylan Inc. in 14-1294. Service: 01/26/2015 by email, US mail. [212804] [Jennifer Swize] [Entered: 01/26/2015 11:51 PM] |
| REPLY of Appellees Mylan Inc. and Mylan Pharmaceuticals Inc. to response filed by Appellee in 14-1294 , Doc. No [111], response filed by Appellants in 14-1294 , Doc. No [114]. Service: 02/02/2015 by email. [214381] [Eric Hunt] [Entered: 02/02/2015 12:10 PM] |
| REPLY of Appellee Teva Pharmaceuticals USA, Inc. to response filed by Appellants in 14-1294 , Doc. No [112]. Service: 02/02/2015 by email. [214607] [Jennell Bilek] [Entered: 02/02/2015 08:24 PM] |
| TENDERED from Appellee Teva Pharmaceuticals USA, Inc.. Title: CONFIDENTIAL REPLY BRIEF Service: 02/02/2015 by email. [214608]. This document has been rejected. See Doc No. [118] [Jennell Bilek] [Entered: 02/02/2015 08:29 PM] |
| NOTICE OF REJECTION: The document of Appellee Teva Pharmaceuticals USA, Inc., Confidential Reply Brief [117], is not in compliance with the rules of this court and is therefore rejected for filing. Service as of this date by Clerk of Court. [214746] [KJ] [Entered: 02/03/2015 01:13 PM] |
| Sealed or confidential document received [Teva Pharmaceutical USA Inc.s Reply in Support of Motion to Dismiss] (corresponding to Doc No. [116]) for Appellee Teva Pharmaceuticals USA, Inc.. Service: 02/03/2015 by email. [214803] [Jennell Bilek] [Entered: 02/03/2015 03:38 PM] |
| MOTION of Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc. for leave to file a response/reply to [119] confidential document , [117] confidential Brief , [116] reply. Response/Opposition is due 02/23/2015 [Consent: not addressed]. Service: 02/09/2015 by email, US mail. [216172] [Jennifer Swize] [Entered: 02/09/2015 11:14 PM] |
| Sealed or confidential document received [Purdues Motion for Leave to File Surreply in Response to Tevas Reply Regarding Tevas Motion to Dismiss (with confidential Exhibit 1)] (corresponding to Doc No. [120]) for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc.. Service: 02/09/2015 by email. [216173] [Jennifer Swize] [Entered: 02/09/2015 11:21 PM] |
| RESPONSE of Appellee Teva Pharmaceuticals USA, Inc. to the motion to file a response/reply [120] filed by Appellants Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.p. and Rhodes Technologies in 14-1294. Service: 02/23/2015 by email. [219312] [Mark Schuman] [Entered: 02/23/2015 05:05 PM] |
| ORDER filed. Tevas motion to dismiss [101] [106] and Purdues motion for leave to file a surreply [120] are deferred for consideration by the merits panel assigned to the case. A copy of this order and the motions papers shall be transmitted to the merits panel. Mylans motion to compel [96] is denied. The stay of the briefing schedule is lifted. The response briefs are due within 30 days from the date of filing of this order.; - FOR CALENDAR.. Service: 03/02/2015 by clerk. [221042] [LMS] [Entered: 03/02/2015 04:10 PM] |
| TENDERED from Appellee Amneal Pharmaceuticals, LLC. Title: RESPONSE BRIEF. Service: 03/30/2015 by email, US mail. [228083] [Barbara Mullin] [Entered: 03/30/2015 05:31 PM] |
| BRIEF FILED for Appellee Amneal Pharmaceuticals, LLC [124]. Number of Pages: 59. Service: 03/30/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/06/2015. [228240] [JCS] [Entered: 03/31/2015 11:23 AM] |
| TENDERED from Appellee Teva Pharmaceuticals USA, Inc.. Title: RESPONSE BRIEF. Service: 04/01/2015 by email. [228821] [Mark Schuman] [Entered: 04/01/2015 05:38 PM] |
| TENDERED from Appellees Mylan Inc. and Mylan Pharmaceuticals Inc.. Title: RESPONSE BRIEF. Service: 04/01/2015 by email. [228828] [William Rakoczy] [Entered: 04/01/2015 06:51 PM] |
| BRIEF FILED for Appellee Teva Pharmaceuticals USA, Inc. [126]. Number of Pages: 61. Service: 04/01/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/08/2015. [229283] [JCS] [Entered: 04/03/2015 09:00 AM] |
| This entry was made in error and has been removed from the docket. [229293] [JCS] [Entered: 04/03/2015 09:24 AM] |
| BRIEF FILED for Appellees Mylan Inc. and Mylan Pharmaceuticals Inc. [127]. Number of Pages: 26. Service: 04/01/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/08/2015. [229307] [JCS] [Entered: 04/03/2015 09:48 AM] |
| 6 paper copies of the Opening Response Brief [125] received from Appellee Amneal Pharmaceuticals, LLC. [229560] [JCS] [Entered: 04/03/2015 03:13 PM] |
| MOTION of Appellants Grunenthal Gmbh, Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and The P.F. Laboratories, Inc. to extend the time to 06/19/2015 to file the reply brief. Response/Opposition is due 04/23/2015 [Consent: unopposed]. Service: 04/08/2015 by email, US mail. [231088] [Jennifer Swize] [Entered: 04/08/2015 04:48 PM] |
| 6 paper copies of the Opening Response Brief [130] received from Appellees Mylan Inc. and Mylan Pharmaceuticals Inc.. [232210] [LAJ] [Entered: 04/13/2015 03:19 PM] |
| 6 paper copies of the Opening Response Brief [130] received from Appellees Mylan Inc. and Mylan Pharmaceuticals Inc.. [232211] [LAJ] [Entered: 04/13/2015 03:22 PM] |
| 6 paper copies of the Opening Response Brief [128] received from Appellee Teva Pharmaceuticals USA, Inc.. [232213] [LAJ] [Entered: 04/13/2015 03:24 PM] |
| ORDER granting motion to extend time to file reply brief [132] filed by Appellants Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.p., Rhodes Technologies and Grunenthal GmbH. Purdue and Grunenthals reply briefs are due on or before June 19, 2015. Service: 04/15/2015 by clerk. [232855] [LMS] [Entered: 04/15/2015 10:50 AM] |
| Official caption revised Per OGCs instructions. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [241631] [JCS] [Entered: 05/18/2015 03:09 PM] |
| TENDERED from Appellants The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies. Title: REPLY BRIEF. Service: 06/19/2015 by email, US mail. [250192] [Jennifer Swize] [Entered: 06/19/2015 08:30 PM] |
| TENDERED from Appellant Grunenthal Gmbh. Title: REPLY BRIEF. Service: 06/19/2015 by email. [250196] [Charles Lipsey] [Entered: 06/19/2015 08:53 PM] |
| REPLY BRIEF FILED for Appellants The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies [138]. Number of Pages: 31. Service: 06/19/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 06/29/2015. [250560] [SJ] [Entered: 06/23/2015 10:08 AM] |
| REPLY BRIEF FILED for Appellant Grunenthal Gmbh [139]. Number of Pages: 32. Service: 06/19/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 06/29/2015. Appendix is due 06/29/2015. [250562] [SJ] [Entered: 06/23/2015 10:10 AM] |
| 6 paper copies of the Reply Brief [141] received from Appellant Grunenthal Gmbh. [251465] [JCS] [Entered: 06/25/2015 02:07 PM] |
| Statement of Compliance with Fed. Cir. R. 33 for Appellants Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and Appellees Amneal Pharmaceuticals, LLC, Mylan Inc., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals USA, Inc.. Service: 06/29/2015 by email, US mail. [252116] [Jennifer Swize] [Entered: 06/29/2015 12:52 PM] |
| TENDERED from Appellants Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies. Title: JOINT APPENDIX. Service: 06/29/2015 by email. [252234] [Jennifer Swize] [Entered: 06/29/2015 04:22 PM] |
| 6 paper copies of the Reply Brief [141] received from Appellants Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies. [252244] [JCS] [Entered: 06/29/2015 04:25 PM] |
| TENDERED from Appellants Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies. Title: JOINT APPENDIX. Service: 06/29/2015 by email. [252248] [Jennifer Swize] [Entered: 06/29/2015 04:27 PM] |
| TENDERED from Appellants Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies. Title: CONFIDENTIAL JOINT APPENDIX Service: 06/29/2015 by email. [252253] [Jennifer Swize] [Entered: 06/29/2015 04:34 PM] |
| TENDERED from Appellants Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies. Title: CONFIDENTIAL JOINT APPENDIX Service: 06/29/2015 by email. [252263] [Jennifer Swize] [Entered: 06/29/2015 04:45 PM] |
| CONFIDENTIAL JOINT APPENDIX Volume 1-8 FILED for Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies [148], [147]. Number of Pages: 4675. Service: 06/29/2015 by email. Pursuant to ECF-10 six paper copies should be filed of the confidential version only. [252909] [JCS] [Entered: 07/01/2015 01:14 PM] |
| APPENDIX FILED for Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies [146], [144]. Number of Pages: 4255. Service: 06/29/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 07/06/2015. [252912] [JCS] [Entered: 07/01/2015 01:25 PM] |
| CLERKS OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account(s) of Ms. Emily Curtis Johnson for Amneal Pharmaceuticals, LLC. One or more e-mail addresses associated with your CM/ECF account, (kwheeler@akingump.com), is invalid and has been returned as undeliverable. Pursuant to ECF-2(E) of the Administrative Order Regarding Electronic Case Filing, an ECF filer must update all contact information with the Pacer Service Center. [253009] [IW] [Entered: 07/01/2015 04:12 PM] |
| 6 paper copies of the appendix volume 1-8 [149] received from Appellants Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies. [253853] [JCS] [Entered: 07/06/2015 02:47 PM] |
| Notice from Appellants The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies regarding conflicts with oral argument (October 5, 6, 7, 9, 2015 & November 6, 2015). Service: 07/06/2015 by email. [253961] [Jennifer Swize] [Entered: 07/06/2015 04:30 PM] |
| Letter from Appellee Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument (October 5-9, 2015). Service: 07/07/2015 by email. [254394] This document has been rejected. See Doc No. [155] [Mark Schuman] [Entered: 07/07/2015 04:37 PM] |
| Notice of Rejection to Appellee Teva Pharmaceuticals USA, Inc., the following document(s) cannot be filed: [154] party letter. Reason(s) Wrong event used..[254466] [JCS] [Entered: 07/08/2015 09:07 AM] |
| Notice from Appellee Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument (October 5-9, 2015). Service: 07/08/2015 by email. [254555] [Mark Schuman] [Entered: 07/08/2015 11:18 AM] |
| REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a), Fed. Cir. R. 47.3 and ECF-2(E) to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [259537] [AT] [Entered: 07/27/2015 10:34 AM] |
| NOTICE OF CALENDARING. Panel: 1511D. Case scheduled Nov 03, 2015 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 10/15/2015. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [274292] THIS NOTICE APPLIES TO CASE(S): [15-1177, 15-1320, 14-1294, 15-1425] [IW] [Entered: 09/22/2015 11:37 AM] |
| MOTION of Appellees Amneal Pharmaceuticals, LLC and Teva Pharmaceuticals USA, Inc. for Separate Arguments. Response/Opposition is due 10/05/2015 [Consent: opposed]. Service: 09/22/2015 by email, US mail. [274539] [Barbara Mullin] [Entered: 09/22/2015 06:31 PM] |
| RESPONSE of Appellants Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies to the motion for other relief [159] filed by Appellees Teva Pharmaceuticals USA, Inc. and Amneal Pharmaceuticals, LLC in 14-1294. Service: 10/02/2015 by email, US mail. [277405] [Jennifer Swize] [Entered: 10/02/2015 06:02 PM] |
| Response to oral argument order from the Appellee Teva Pharmaceuticals USA, Inc.. designating Mark D. Schuman as arguing attorney. Designated time for argument: 7 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [280782] [Mark Schuman] [Entered: 10/15/2015 04:00 PM] |
| Response to oral argument order from the Appellee Amneal Pharmaceuticals, LLC. designating Barbara L. Mullin as arguing attorney. Designated time for argument: 6 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [280792] [Barbara Mullin] [Entered: 10/15/2015 04:26 PM] |
| Response to oral argument order from the Appellees Mylan Inc. and Mylan Pharmaceuticals Inc.. designating William A. Rakoczy as arguing attorney. Designated time for argument: 2 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [280803] [William Rakoczy] [Entered: 10/15/2015 05:11 PM] |
| Response to oral argument order from the Appellants Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies. designating Gregory A. Castanias as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [280817] [Jennifer Swize] [Entered: 10/15/2015 05:43 PM] |
| ORDER filed. Amneals and Tevas joint motion to divide oral argument into two separate 20 minute sessions is denied. The total argument time is expanded to 40 minutes, with each side being allotted 20 minutes for argument. [159] Purdues motion for leave to file a surreply is denied. [120] By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [280832] [ALT] [Entered: 10/15/2015 09:11 PM] |
| Response to oral argument order from the Appellee Amneal Pharmaceuticals, LLC. designating Barbara L. Mullin as arguing attorney. Designated time for argument: 8 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [283496] [Barbara Mullin] [Entered: 10/26/2015 04:12 PM] |
| Response to oral argument order from the Appellee Teva Pharmaceuticals USA, Inc.. designating Mark D. Schuman as arguing attorney. Designated time for argument: 9 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [283505] [Mark Schuman] [Entered: 10/26/2015 04:35 PM] |
| Response to oral argument order from the Appellees Mylan Inc. and Mylan Pharmaceuticals Inc.. designating William A. Rakoczy as arguing attorney. Designated time for argument: 3 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [283570] [William Rakoczy] [Entered: 10/26/2015 09:23 PM] |
| Response to oral argument order from the Appellants Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies. designating Gregory A. Castanias as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [283706] [Gregory Castanias] [Entered: 10/27/2015 11:44 AM] |
| Submitted after ORAL ARGUMENT by Mr. Gregory A. Castanias for Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.p., Rhodes Technologies, and Grunenthal GmbH Barbara Mullin for Amneal Pharmaceuticals, LLC Mr. Mark David Schuman for Teva Pharmaceuticals USA, Inc. and William A. Rakoczy for Mylan Pharmaceuticals Inc. and Mylan Inc. Panel: Judge: Prost , Judge: Reyna , Judge: Stark. [285577]--[Edited 01/29/2016 by clerk to correct docket text] [JAB] [Entered: 11/03/2015 10:38 AM] |
| MOTION of Appellants The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies to withdraw counsel Pablo D. Hendler. Response/Opposition is due 02/11/2016 [Consent: unopposed]. Service: 01/28/2016 by email, US mail. [306848] [Pablo Hendler] [Entered: 01/28/2016 04:51 PM] |
| ORDER filed granting motion to withdraw attorney PABLO D. HENDLER [171] filed by Appellants Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.p. and Rhodes Technologies. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [307063] [AT] [Entered: 01/29/2016 01:25 PM] |
| OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Prost,Chief Judge; Reyna,Circuit Judge and Stark,Chief Judge). [307297] [14-1294, 14-1296, 14-1306, 14-1307, 14-1311, 14-1312, 14-1313, 14-1314] [JW] [Entered: 02/01/2016 10:10 AM] |
| ORDER filed denying [106] [101] motion to terminate cross/consolidated appeal filed by Teva Pharmaceuticals USA, Inc. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [307304]--[Edited 02/08/2016 by the clerk AT - to update the document access pursuant to the courts order filed 2/8/16] [JW] [Entered: 02/01/2016 10:22 AM] |
| ORDER filed to show cause; The parties are hereby ordered to show cause why the order filed on 02/01/2016 should not be unsealed. Appellees and Appellants response to the show cause order is due on or before 02/08/2016. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [307310] [JW] [Entered: 02/01/2016 10:30 AM] |
| RESPONSE of Appellants The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p., Rhodes Technologies and Appellee Teva Pharmaceuticals USA, Inc. to the court order to show cause [175] ,court order [175]. Service: 02/05/2016 by email, US mail. [309014] [Jennifer Swize] [Entered: 02/05/2016 04:19 PM] |
| RESPONSE of Appellees Mylan Inc. and Mylan Pharmaceuticals Inc. to the court order to show cause [175] ,court order [175]. Service: 02/08/2016 by email. [309257] [Amy Brody] [Entered: 02/08/2016 11:55 AM] |
| ORDER filed: The courts order filed on February 1, 2016 [174] is unsealed. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [309387]--[ENTRY EDITED 02/08/2016 by the clerk AT to correct the document link] [AT] [Entered: 02/08/2016 03:45 PM] |
| Bill of Costs for Appellees Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 02/16/2016 by email, US mail. Objection to Bill of Costs due on 03/04/2016. [311531] [Amy Brody] [Entered: 02/16/2016 09:11 PM] |
| MOTION of Appellants Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 04/01/2016. Response/Opposition is due 03/10/2016 [Consent: not addressed]. Service: 02/24/2016 by email, US mail. [313748] [Jennifer Swize] [Entered: 02/24/2016 08:11 PM] |
| MOTION of Appellants Grunenthal Gmbh, The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 04/01/2016. Response/Opposition is due 03/14/2016 [Consent: partial consent]. Service: 02/29/2016 by email, US mail. [314593] [Jennifer Swize] [Entered: 02/29/2016 02:53 PM] |
| ORDER filed granting motion to extend time to file petition for rehearing [181] [180] filed by Appellants Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.p., Rhodes Technologies and Grunenthal Gmbh. The due date for filing petitions for rehearing in this matter is extended to April 1, 2016. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [315179] [AT] [Entered: 03/02/2016 08:50 AM] |
| Notice to counsel for Appellants The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and Rhodes Technologies: The record of this case indicates that the Amended Certificate of Interest has not been filed as required by Rule 47.4(c). Attorney SONA DE must also file an amended entry of appearance reflecting her change of law firm affiliation. Service as of this date by Clerk of Court. [323008] [AT] [Entered: 03/31/2016 08:05 AM] |
| MOTION of Appellants The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies to withdraw counsel Sona De. Response/Opposition is due 04/14/2016 [Consent: unopposed]. Service: 03/31/2016 by email. [323088] [Sona De] [Entered: 03/31/2016 11:02 AM] |
| Amended Certificate of Interest for the Appellants The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies. Service: 03/31/2016 by email, US mail. [323155] [Jennifer Swize] [Entered: 03/31/2016 02:15 PM] |
| ORDER filed granting motion to withdraw attorney SONA DE [184] filed by Appellants Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P. and Rhodes Technologies. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [323176] [AT] [Entered: 03/31/2016 03:15 PM] |
| Petition for en banc rehearing filed by Appellants The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies. Service: 04/01/2016 by email, US mail. The paper copies of the petition must be filed within two business days (see ECF-10(d)).The required paper copies should be received by the court on or before 04/05/2016 [323432] [Jennifer Swize] [Entered: 04/01/2016 05:35 PM] |
| Petition for panel rehearing, for en banc rehearing filed by Appellant Grunenthal Gmbh. Service: 04/01/2016 by email, US mail. The paper copies of the petition must be filed within two business days (see ECF-10(d)).The required paper copies should be received by the court on or before 04/05/2016 [323435] [Charles Lipsey] [Entered: 04/01/2016 06:21 PM] |
| 18 paper copies of the petition for rehearing [188] received from Appellant Grunenthal Gmbh. [324008] [AT] [Entered: 04/05/2016 12:03 PM] |
| 18 paper copies of the petition for en banc rehearing [187] received from Appellants The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies. [324104] [LAJ] [Entered: 04/05/2016 02:33 PM] |
| 18 paper copies of the petition for en banc rehearing [187] received from Appellants The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals L.p. and Rhodes Technologies. [324112] [AT] [Entered: 04/05/2016 02:44 PM] |
| Entry of appearance for Jeffrey I.D. Lewis as principal counsel for Professor Richard E. Kouri, Ph.D.. Service: 04/14/2016 by email. [326568] [Jeffrey Lewis] [Entered: 04/14/2016 04:45 PM] |
| Entry of appearance for Randy Eisensmith as of counsel for Professor Richard E. Kouri, Ph.D.. Service: 04/14/2016 by email. [326576] [Randy Eisensmith] [Entered: 04/14/2016 04:53 PM] |
| MOTION of Professor Richard E. Kouri, Ph.D. for leave to file amicus brief in support of Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P., and Rhodes Technologies on petition for en banc rehearing [187]. Response/Opposition is due 04/28/2016 [Consent: partial consent]. Service: 04/14/2016 by email. [326579] [Jeffrey Lewis] [Entered: 04/14/2016 05:05 PM] |
| TENDERED from Professor Richard E. Kouri, Ph.D. Title: AMICUS CURIAE BRIEF. Service: 04/14/2016 by email. [326583] [Jeffrey Lewis] [Entered: 04/14/2016 05:13 PM] |
| Entry of appearance for Joseph Vincent Micali as of counsel for Professor Richard E. Kouri, Ph.D.. Service: 04/14/2016 by email. [326586] [Joseph Micali] [Entered: 04/14/2016 05:22 PM] |
| MOTION of Amici Curiae Mark David Janis and Mr. Donald E. Knebel for leave to file an amicus curiae brief. Response/Opposition is due 04/28/2016 [Consent: unopposed]. Service: 04/15/2016 by email, US mail. [326668] [Mark Janis] [Entered: 04/15/2016 10:30 AM] |
| TENDERED from Amici Curiae Mark David Janis and Mr. Donald E. Knebel. Title: AMICUS CURIAE BRIEF. Service: 04/15/2016 by email. [326672] [Mark Janis] [Entered: 04/15/2016 10:33 AM] |
| Entry of appearance for Kevin A. OConnor as principal counsel for The Intellectual Property Law Association of Chicago. Service: 04/15/2016 by email, US mail. [326909] [Kevin OConnor] [Entered: 04/15/2016 04:49 PM] |
| MOTION of The Intellectual Property Law Association of Chicago for leave to file an amicus curiae brief. Response/Opposition is due 04/28/2016 [Consent: partial consent]. Service: 04/15/2016 by email, US mail. [326914] [Kevin OConnor] [Entered: 04/15/2016 04:59 PM] |
| TENDERED from The Intellectual Property Law Association of Chicago Title: AMICUS CURIAE BRIEF. Service: 04/15/2016 by email, US mail. [326916] [Kevin OConnor] [Entered: 04/15/2016 05:13 PM] |
| Entry of appearance for Kevin C. May as of counsel for The Intellectual Property Law Association of Chicago. Service: 04/15/2016 by email, US mail. [326917] [Kevin May] [Entered: 04/15/2016 05:23 PM] |
| ORDER filed granting motions for leave to file an amicus curiae brief on en banc or rehearing petition [200], [197], [194]. By: (Per Curiam). Service as of this date by Clerk of Court. [327289] [SJ] [Entered: 04/18/2016 04:41 PM] |
| AMICUS BRIEF FILED on Petition for Intellectual Property Law Association of Chicago[201]. Pages: 10. Pursuant to ECF-10(D), the filer is directed to submit the approriate number of copies within two days. [327358] [AT] [Entered: 04/19/2016 07:44 AM] |
| AMICUS BRIEF FILED on Petition for Mark David Janis and Mr. Donald E. Knebel[198]. Pages: 10. Pursuant to ECF-10(D), the filer is directed to submit the approriate number of copies within two days. [327360] [AT] [Entered: 04/19/2016 07:46 AM] |
| AMICUS BRIEF FILED on Petition for Richard E. Kouri[195]. Pages: 10. Pursuant to ECF-10(D), the filer is directed to submit the approriate number of copies within two days. [327361] [AT] [Entered: 04/19/2016 07:48 AM] |
| 16 paper copies of the amicus Brief [204] received from Amicus Curiae Intellectual Property Law Association of Chicago. [327684] [AT] [Entered: 04/19/2016 03:09 PM] |
| CLERKS OFFICE QUALITY CONTROL MESSAGE: re:Paper copies of the brief of amicus IPLA-Chicago Docket No. [207], ERROR: The paper copies have a white cover and are not securely bound. CORRECTION: Paper copies of amicus briefs must have a green cover and be securely bound. Please re-file 16 paper copies within 2 business days. [327687] [AT] [Entered: 04/19/2016 03:12 PM] |
| 6 paper copies of the amicus Brief [206] received from Amicus Curiae Richard E. Kouri. [327716] [AT] [Entered: 04/19/2016 03:35 PM] |
| CLERKS OFFICE QUALITY CONTROL MESSAGE: re:paper copies of the brief of amicus Richard E. Kouri Docket No. [209], ERROR: only 6 paper copies of the amicus brief were received; per rule ECF 10(D), 16 copies are required. CORRECTION: Please transmit 10 additional paper copies of the brief within 2 business days. [327721]--[EDITED 04/19/2016 by the clerk - to clarify the party filer] [AT] [Entered: 04/19/2016 03:38 PM] |
| 10 addtl paper copies of the amicus Brief [206] received from Amicus Curiae Richard E. Kouri. [328176] [AT] [Entered: 04/20/2016 03:24 PM] |
| 16 paper copies of the amicus Briefs [205], [204] received from Amici Curiae Intellectual Property Law Association of Chicago, and Mark David Janis and Mr. Donald E. Knebel. [328387] [AT] [Entered: 04/21/2016 11:38 AM] |
| ORDER filed denying [188] petition for panel rehearing and rehearing en banc filed by Grunenthal Gmbh; denying [187] petition for rehearing en banc filed by Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P. and Rhodes Technologies. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [332133] [AT] [Entered: 05/04/2016 12:39 PM] |
| Mandate issued to the United States District Court for the Southern District of New York. Costs taxed in the amount of $243.77. Service as of this date by Clerk of Court. [333970] [14-1294, 14-1296, 14-1306, 14-1307, 14-1311, 14-1312, 14-1313, 14-1314] [AT] [Entered: 05/11/2016 07:26 AM] |
| Petition for writ of Certiorari filed on 09/01/2016 in the Supreme Court of the United States. Supreme Court #: 16-289, Purdue Pharma L.P. v. Epic Pharma, LLC. [365136] [AT] [Entered: 09/08/2016 11:45 AM] |
| Petition for writ of Certiorari filed on 09/01/2016 in the Supreme Court of the United States. Supreme Court #: 16-296, Grunenthal Gmbh v. Teva Pharmaceuticals USA. [365272] [14-1294, 14-1311] [AT] [Entered: 09/08/2016 02:56 PM] |
| The petition for writ of certiorari, [16-296], filed on 09/01/2016, was Denied on 11/14/2016. [382685] [AT] [Entered: 11/14/2016 03:27 PM] |
| The petition for writ of certiorari, [16-289], filed on 09/01/2016, was Denied on 11/14/2016. [382688] [AT] [Entered: 11/14/2016 03:28 PM] |
Timeline
filed_date
closed_date
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2015
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2016
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2017
Patents In Case